ACURA PHARMACEUTICALS, INC Contracts & Agreements
118 Contracts & Agreements
- Business Finance (68 contracts)
- Business Operations (6)
- Human Resources (17)
- Intellectual Property (6)
- Real Estate (1)
- Uncategorized (20)
- Amendment #2 to the License, Development and Commercialization Agreement is made and entered into as of June 17, 2021 by the Registrant and between Abuse Deterrent Pharma, LLC (Filed With SEC on June 30, 2023)
- Third Amendment to the Amended License, Development and Commercialization Agreement is made and entered into as of February 28, 2022 by the Registrant and between Abuse Deterrent... (Filed With SEC on June 30, 2023)
- Amended, Consolidated and Restated Secured Promissory Note dated November 10, 2022 issued to John Schutte (Filed With SEC on June 30, 2023)
- Amended Loan Schedule to the Amended, Consolidated and Restated Secured Promissory Note dated November 10, 2022 issued to Abuse Deterrent Pharma, LLC on May 19, 2023 aggregating... (Filed With SEC on June 30, 2023)
- Acura Pharmaceuticals Inc. 2021 Restricted Stock Unit Award Plan (Filed With SEC on May 27, 2021)
- Amended License, Development and Commercialization Agreement is made and entered into as of October 16, 2020 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC (Filed With SEC on March 31, 2021)
- License, Development and Commercialization Agreement is made and entered into as of June 28, 2019 by the Registrant and between Abuse Deterrent Pharmaceuticals, LLC (Filed With SEC on March 31, 2020)
- Common Stock Warrant issued June 28, 2019 to John Schutte (Filed With SEC on March 31, 2020)
- Assignment of Promissory Note, Warrant and Security Agreement issued June 28, 2019 by John Schutte to Abuse Deterrent Pharmaceuticals, LLC (Filed With SEC on March 31, 2020)
- Promissory Note Dated June 28, 2019 (Filed With SEC on February 28, 2020)
- Promissory Note Dated May 1, 2019 (Filed With SEC on February 10, 2020)
- Promissory Note Dated June 12, 2019 (Filed With SEC on February 10, 2020)
- Promissory Note Dated March 25, 2019 (Filed With SEC on October 1, 2019)
- Promissory Note dated October 5, 2018 issued to John Schutte (Filed With SEC on September 16, 2019)
- Promissory Note dated November 21, 2018 issued to John Schutte (Filed With SEC on September 16, 2019)
- Promissory Note dated December 20, 2018 issued to John Schutte (Filed With SEC on September 16, 2019)
- Promissory Note dated January 28, 2019 issued to John Schutte (Filed With SEC on September 16, 2019)
- Promissory Note dated August 2, 2018 issued to John Schutte (Filed With SEC on November 27, 2018)
- Promissory Note dated September 13, 2018 issued to John Schutte (Filed With SEC on November 27, 2018)
- Promissory Note dated May 7, 2018 issued to John Schutte (Filed With SEC on August 14, 2018)
- Subordination Agreement dated as of May 7, 2018 between John Schutte and Oxford Finance, LLC, approved by Registrant and Acura Pharmaceutical Technologies, Inc (Filed With SEC on August 14, 2018)
- Fourth Amendment dated as of June 6, 2018 to Loan and Security Agreement dated as of December 27, 2013, as amended, between the Registrant, Acura Pharmaceutical Technologies, Inc.... (Filed With SEC on August 14, 2018)
- Promissory Note dated June 28, 2018 issued to John Schutte (Filed With SEC on August 14, 2018)
- License, Commercialization and Option Agreement is made and entered into as of March 16, 2017 by and between MainPointe Pharmaceuticals, LLC (Filed With SEC on June 7, 2018)
- Acura Pharmaceuticals Inc. 2017 Restricted Stock Unit Award Plan (Filed With SEC on November 14, 2017)
- SECOND AMENDED AND RESTATED VOTINGAGREEMENT (Filed With SEC on August 1, 2017)
- COMMON STOCK PURCHASE WARRANT (Filed With SEC on July 28, 2017)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on July 28, 2017)
- SECOND AMENDED AND RESTATED VOTINGAGREEMENT (Filed With SEC on July 28, 2017)
- INTELLECTUAL PROPERTY SECURITY AGREEMENT (Filed With SEC on May 12, 2017)
- CONSENT AND THIRD AMENDMENT TO LOANAND SECURITY AGREEMENT (Filed With SEC on May 12, 2017)
- CONSENT AND SECOND AMENDMENT TO LOANAND SECURITY AGREEMENT (Filed With SEC on February 3, 2017)
- ACURA PHARMACEUTICALS INC. 2016 STOCKOPTION PLAN (Filed With SEC on April 28, 2016)
- LICENSEAND DEVELOPMENT AGREEMENT (Filed With SEC on August 3, 2015)
- PLACEMENT AGENCY AGREEMENT (Filed With SEC on July 1, 2015)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on July 1, 2015)
- FIRST AMENDMENT TO LOAN AND SECURITYAGREEMENT (Filed With SEC on March 2, 2015)
- AMENDED AND RESTATED WARRANT TO PURCHASESTOCK (A1) (Filed With SEC on March 2, 2015)
- AMENDED AND RESTATED WARRANT TO PURCHASESTOCK (A2) (Filed With SEC on March 2, 2015)
- AMENDED AND RESTATED WARRANT TO PURCHASESTOCK (A3) (Filed With SEC on March 2, 2015)
- Collaboration and licenseagreement Between Acura pharmaceuticals, inc. Egalet US, Inc. And Egalet Limited Dated January 7, 2015 (Filed With SEC on March 2, 2015)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on March 3, 2014)
- FORM1 OF WARRANT TO PURCHASESTOCK (A__) (Filed With SEC on March 3, 2014)
- MORTGAGE, ASSIGNMENT OF RENTS AND LEASES, SECURITY AGREEMENT AND FIXTURE FILING by and from ACURA PHARMACEUTICAL TECHNOLOGIES, INC., an Indiana corporation, “Mortgagor” to... (Filed With SEC on March 3, 2014)
- SEVENTH AMENDMENT TO EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on March 3, 2014)
- STRATEGIC TRANSACTION BONUS GRANT AGREEMENT (Filed With SEC on May 2, 2013)
- STRATEGIC TRANSACTION BONUS GRANT AGREEMENT (Filed With SEC on May 2, 2013)
- ACURA PHARMACEUTICALS, INC. Common Stock (par value $0.01 per share) At Market Issuance Sales Agreement (Filed With SEC on April 18, 2013)
- SECOND AMENDMENT TO EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on December 17, 2012)
- SIXTH AMENDMENT TO EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on December 17, 2012)
- THIRD AMENDMENT TO AMENDED AND RESTATEDVOTING AGREEMENT (Filed With SEC on October 3, 2012)
- UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION (Filed With SEC on November 4, 2011)
- Exhibit 10.1 AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 28, 2011)
- Exhibit 10.2 SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 28, 2011)
- Manufacturing Services Agreement JULY 19, 2011By and Between Acura Pharmaceuticals, Inc. andPatheon Pharmaceuticals Inc. [***Confidential Treatment requested pursuant to a request... (Filed With SEC on July 27, 2011)
- CONSULTINGAGREEMENT (Filed With SEC on March 2, 2010)
- EMPLOYMENTAGREEMENT (Filed With SEC on May 1, 2009)
- FIFTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2008)
- THIRD AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2008)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2008)
- FIFTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 10, 2008)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 24, 2008)
- FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2008)
- SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2008)
- FOURTH AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on March 5, 2008)
- SECOND AMENDMENT TO AMENDED AND RESTATED VOTING AGREEMENT (Filed With SEC on January 28, 2008)
- LICENSE, DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN ACURA PHARMACEUTICALS, INC. AND KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC. (Filed With SEC on November 2, 2007)
- SIXTH AMENDMENT, WAIVER AND CONSENT TO LOAN AGREEMENT (Filed With SEC on September 24, 2007)
- SECURED PROMISSORY NOTE (Filed With SEC on September 24, 2007)
- ACURA PHARMACEUTICALS, INC. WARRANT (Filed With SEC on August 21, 2007)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 21, 2007)
- FIFTH AMENDMENT, WAIVER AND CONSENT TO LOAN AGREEMENT (Filed With SEC on August 21, 2007)
- SECURED PROMISSORY NOTE (Filed With SEC on August 21, 2007)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on July 10, 2007)
- FOURTH AMENDMENT, WAIVER AND CONSENT TO LOAN AGREEMENT (Filed With SEC on July 5, 2007)
- CONSENT AND AMENDMENT TO NOTEHOLDERS AGREEMENT (Filed With SEC on July 5, 2007)
- SECURED PROMISSORY NOTE (Filed With SEC on July 5, 2007)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on April 2, 2007)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on December 4, 2006)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on October 20, 2006)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on September 25, 2006)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on August 16, 2006)
- OMNIBUS AMENDMENT AND CONSENT (Filed With SEC on May 24, 2006)
- FIRST AMENDEMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on February 21, 2006)
- SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 21, 2006)
- VOTING AGREEMENT (Filed With SEC on February 21, 2006)
- LOAN AGREEMENT (Filed With SEC on January 31, 2006)
- SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC. $______________________ No. N-__ January 31, 2006 (Filed With SEC on January 31, 2006)
- COMPANY GENERAL SECURITY AGREEMENT (Filed With SEC on January 31, 2006)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on January 31, 2006)
- GUARANTOR GENERAL SECURITY AGREEMENT (Filed With SEC on January 31, 2006)
- STOCK PLEDGE AGREEMENT (Filed With SEC on January 31, 2006)
- THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2005)
- AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2005)
- THIRD AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on December 23, 2005)
- ACURA PHARMACEUTICALS, INC. 2005 RESTRICTED STOCK UNIT AWARD PLAN (Filed With SEC on December 23, 2005)
- JOINDER AND AMENDMENT TO AMENDED AND RESTATED VOTING AGREEMENT (Filed With SEC on November 10, 2005)
- LOAN AGREEMENT (Filed With SEC on November 10, 2005)
- SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC. (Filed With SEC on November 10, 2005)
- COMPANY GENERAL SECURITY AGREEMENT (Filed With SEC on November 10, 2005)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on November 10, 2005)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on November 10, 2005)
- GUARANTORS GENERAL SECURITY AGREEMENT (Filed With SEC on November 10, 2005)
- STOCK PLEDGE AGREEMENT (Filed With SEC on November 10, 2005)
- LOAN AGREEMENT (Filed With SEC on September 16, 2005)
- SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC. (Filed With SEC on September 16, 2005)
- COMPANY GENERAL SECURITY AGREEMENT (Filed With SEC on September 16, 2005)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on September 16, 2005)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on September 16, 2005)
- GUARANTORS GENERAL SECURITY AGREEMENT (Filed With SEC on September 16, 2005)
- STOCK PLEDGE AGREEMENT (Filed With SEC on September 16, 2005)
- LOAN AGREEMENT (Filed With SEC on June 23, 2005)
- SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC. $__________ No. N-__ June 22, 2005 (Filed With SEC on June 23, 2005)
- COMPANY GENERAL SECURITY AGREEMENT (Filed With SEC on June 23, 2005)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on June 23, 2005)
- CONTINUING UNCONDITIONAL SECURED GUARANTY (Filed With SEC on June 23, 2005)
- GUARANTORS GENERAL SECURITY AGREEMENT (Filed With SEC on June 23, 2005)
- STOCK PLEDGE AGREEMENT (Filed With SEC on June 23, 2005)